Tratamento de complicações clínicas e intercorrências de pacientes oncológicos no Sistema Único de Saúde do Brasil

Abstract

Cancer treatment can be a challenging experience for patients, especially when dealing with clinical complications. In Brazil, the public healthcare system (Sistema Único de Saúde) offers therapies and care to cancer patients, and it is necessary to investigate the offer of both over time. Therefore, the objective of this investigation was to evaluate the treatment for cancerrelated clinical complications and intercurrences in the Brazilian Unified Health System between 2013 and 2021. An ecological, analytical and quantitative study was carried out with data collected from the Hospital Information System (SIH/SUS) available in open access. Two hospital procedures related to the treatment of clinical complications and intercurrences resulting from cancer were selected. The annual number of both procedures was normalized by the number of new cases of cancer diagnosed in the SUS (as a proxy measure to correct for the effect of population size). Data were analyzed with a significance level of 5%. A significant and decreasing tendency was observed for both hospital procedures investigated over the delimited time. Moreover, the COVID-19 pandemic did not influence this outcome. Therefore, it is understood that the offer of treatment for clinical complications and intercurrences was unsatisfactory for the number of new cases of cancer diagnosed in the SUS in the last nine years in Brazil.